GlassScriptPhysician profile
Roshan Razik
NPI 1306353347
$3,450.20
in general payments reported to CMS, 2019-2025
9 companies · $2,200 in 2025
The $2,200 reported for 2025 was more than what 81% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2022: $378 · 2023: $335 · 2024: $154 · 2025: $2,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,115 · Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,115.00 |
| Food and Beverage | $574.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Medical Systems Corporation | $2,065.00 | 2025 | Gastrointestinal Videoscope |
| Abbvie INC. | $349.28 | 2019-2022 | |
| Janssen Biotech, INC. | $272.05 | 2023 | Stelara |
| Boston Scientific Corporation | $222.04 | 2022-2024 | Resolution 360 Ultra Clip |
| Pfizer INC. | $145.00 | 2019 | |
| Madrigal Pharmaceuticals | $134.67 | 2025 | Rezdiffra |
| Takeda Pharmaceuticals U.S.A., INC. | $132.08 | 2019-2023 | Entyvio |
| Medical Device Business Services, INC. | $102.50 | 2024 | Enseal |
| Phathom Pharmaceuticals, INC. | $27.58 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roshan Razik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.